FI104174B1 - A process for the preparation of a therapeutically useful nonane isomer of 1,4-dihydro-4-oxo-3-quinolinecarboxylic acid 7- [S, S] -2,8-diazabicyclo [4.3.0] - Google Patents

A process for the preparation of a therapeutically useful nonane isomer of 1,4-dihydro-4-oxo-3-quinolinecarboxylic acid 7- [S, S] -2,8-diazabicyclo [4.3.0]

Info

Publication number
FI104174B1
FI104174B1 FI930049A FI930049A FI104174B1 FI 104174 B1 FI104174 B1 FI 104174B1 FI 930049 A FI930049 A FI 930049A FI 930049 A FI930049 A FI 930049A FI 104174 B1 FI104174 B1 FI 104174B1
Authority
FI
Finland
Prior art keywords
diazabicyclo
dihydro
oxo
preparation
therapeutically useful
Prior art date
Application number
FI930049A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI930049A0 (en
FI930049A (en
FI104174B (en
Inventor
Uwe Petersen
Andreas Krebs
Thomas Schenke
Thomas Philipps
Klaus Grohe
Klaus-Dieter Bremm
Rainer Endermann
Karl-Georg Metzger
Ingo Haller
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27203290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI104174(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE4200414A external-priority patent/DE4200414A1/en
Priority claimed from DE4208792A external-priority patent/DE4208792A1/en
Priority claimed from DE4208789A external-priority patent/DE4208789A1/en
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI930049A0 publication Critical patent/FI930049A0/en
Publication of FI930049A publication Critical patent/FI930049A/en
Priority to FI971012A priority Critical patent/FI971012A0/en
Application granted granted Critical
Publication of FI104174B publication Critical patent/FI104174B/en
Publication of FI104174B1 publication Critical patent/FI104174B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI930049A 1992-01-10 1993-01-07 A process for the preparation of a therapeutically useful nonane isomer of 1,4-dihydro-4-oxo-3-quinolinecarboxylic acid 7- [S, S] -2,8-diazabicyclo [4.3.0] FI104174B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI971012A FI971012A0 (en) 1992-01-10 1997-03-11 1,4-dihydro-4-oxo-3-quinoline carboxylic acid derivatives and their use

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4200414A DE4200414A1 (en) 1992-01-10 1992-01-10 New quinoline and naphthyridinone-carboxylic acid derivs.
DE4200414 1992-01-10
DE4208792A DE4208792A1 (en) 1992-03-19 1992-03-19 New quinoline and naphthyridinone-carboxylic acid derivs.
DE4208789A DE4208789A1 (en) 1992-03-19 1992-03-19 New quinoline and naphthyridinone-carboxylic acid derivs.
DE4208792 1992-03-19
DE4208789 1992-03-19

Publications (4)

Publication Number Publication Date
FI930049A0 FI930049A0 (en) 1993-01-07
FI930049A FI930049A (en) 1993-07-11
FI104174B FI104174B (en) 1999-11-30
FI104174B1 true FI104174B1 (en) 1999-11-30

Family

ID=27203290

Family Applications (3)

Application Number Title Priority Date Filing Date
FI930049A FI104174B1 (en) 1992-01-10 1993-01-07 A process for the preparation of a therapeutically useful nonane isomer of 1,4-dihydro-4-oxo-3-quinolinecarboxylic acid 7- [S, S] -2,8-diazabicyclo [4.3.0]
FI990207A FI110943B (en) 1992-01-10 1999-02-03 Enantiomerically pure 2,8-diazabicyclo [4.3.0] nonane derivatives
FI20020059A FI113771B (en) 1992-01-10 2002-01-11 Enantiomerically pure (1S, 6S) -2-oxa-5,8-diazabicyclo [4.3.0] nonane

Family Applications After (2)

Application Number Title Priority Date Filing Date
FI990207A FI110943B (en) 1992-01-10 1999-02-03 Enantiomerically pure 2,8-diazabicyclo [4.3.0] nonane derivatives
FI20020059A FI113771B (en) 1992-01-10 2002-01-11 Enantiomerically pure (1S, 6S) -2-oxa-5,8-diazabicyclo [4.3.0] nonane

Country Status (16)

Country Link
EP (1) EP0550903A1 (en)
JP (3) JPH05271229A (en)
KR (1) KR100251886B1 (en)
CN (3) CN1043142C (en)
AU (1) AU669502B2 (en)
CA (1) CA2086914C (en)
CZ (1) CZ289076B6 (en)
FI (3) FI104174B1 (en)
HU (1) HU219488B (en)
MX (1) MX9207604A (en)
MY (1) MY115416A (en)
NO (1) NO301420B1 (en)
NZ (1) NZ245640A (en)
PL (1) PL174853B1 (en)
SK (3) SK282971B6 (en)
TW (1) TW209865B (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04445A (en) 1990-04-17 1992-01-06 Fuji Photo Film Co Ltd Processing method for silver halide color photosensitive material
EP0720049B1 (en) 1990-05-09 1999-08-04 Fuji Photo Film Co., Ltd. Photographic processing composition and processing method using the same
DE4121214A1 (en) * 1991-06-27 1993-01-14 Bayer Ag 7-AZAISOINDOLINYL CHINOLONE AND NAPHTHYRIDONE CARBONIC ACID DERIVATIVES
CA2112165C (en) * 1992-12-25 2003-04-08 Makoto Takemura Bicyclic amine derivatives
KR0148277B1 (en) * 1993-01-18 1998-11-02 채영복 Novel fluoroquinolone derivatives and process for the preparation thereof
DE4301246A1 (en) * 1993-01-19 1994-07-21 Bayer Ag Quinolone and naphthyridonecarboxylic acid derivatives
JP3372994B2 (en) 1993-06-11 2003-02-04 富士写真フイルム株式会社 Processing method of silver halide color photographic light-sensitive material
DE4329600A1 (en) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d, e] [1,3,4] benzoxadiazine derivatives
KR950018003A (en) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 Novel quinolone derivatives and methods for their preparation
DE4342186A1 (en) * 1993-12-10 1995-06-14 Bayer Ag One-pot process for the production of 3-quinolonecarboxylic acid derivatives
DE4418510A1 (en) * 1994-05-27 1995-11-30 Bayer Ag 1,9-bridged thiazolol [3,4-a] quinoline derivatives
AU6221296A (en) * 1995-06-07 1996-12-30 Bayer Aktiengesellschaft Testing device for determining the susceptibility of microor ganisms to inhibitory agents
DE19546249A1 (en) * 1995-12-12 1997-06-19 Bayer Ag New crystal modification of 1-cyclopropyl-7 - ([S, S] -2,8-diazabicyclo [4,3,0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4 -oxo-3-quinoline carboxylic acid hydrochloride (CDCH), process for its preparation and pharmaceutical preparations containing it
DE19652239A1 (en) * 1996-12-16 1998-06-18 Bayer Ag Use of 7- (2-oxa-5,8-diazabicyclo [4.3.0] non-8-yl) -quinolone and naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and the associated gastroduodenal diseases
DE19735198A1 (en) * 1997-08-14 1999-02-18 Bayer Ag Optical resolution of cis- or trans-pyrrolo:piperidine derivatives
BR9812553B1 (en) * 1997-09-25 2010-06-01 drug formulation in controlled diffusion pellet and matrix system.
DE19751948A1 (en) * 1997-11-24 1999-05-27 Bayer Ag Rapid preparation of 8-alkoxy-quinolone-carboxylic acid derivative antibacterial agent, e.g. gatifloxacin, in high purity
DE19821039A1 (en) * 1998-05-11 1999-11-18 Bayer Ag Production of (S,S)-8-benzyl-2,8-diazabicyclo(4.3.0)nonane useful as intermediate for antibiotic moxifloxacin
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
AR020661A1 (en) * 1998-09-30 2002-05-22 Alcon Lab Inc A PHARMACEUTICAL COMPOSITION TOPICA OFTALMICA, OTICA OR NASAL AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
EE04418B1 (en) * 1998-11-10 2005-02-15 Bayer Aktiengesellschaft Pharmaceutical preparation of moxifloxacin
KR100768034B1 (en) 1999-03-17 2007-10-17 다이이찌 세이야꾸 가부시기가이샤 Pharmaceutical composition
DE19927412A1 (en) 1999-06-16 2000-12-21 Bayer Ag Process for the enantiomeric enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0] nonane
DE19931115A1 (en) * 1999-07-06 2001-01-11 Bayer Ag Racemization of R, S-dioxo-benzylpyrrolopiperidine
DE19962470A1 (en) 1999-12-22 2001-07-12 Schulz Hans Herrmann Use of chemotherapy drugs
DE10226923A1 (en) * 2002-06-17 2003-12-24 Bayer Ag Process for the enantiomer enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0] nonane
ES2319125T3 (en) * 2003-11-20 2009-05-04 Chemi S.P.A. POLYMORPHES OF ACID CHLORHYDRATE 1-CICLOPROPIL-7 - ((S, S) -2,8-DIAZADICICLO (4.3.0) -NON-8-IL) -6-FLUORO-1,4-DIHYDRO-8-METOXI- 4-OXO-3-CARBOXYLIN CHINOLINE AND METHODS FOR THE PREPARATION OF THE SAME.
ITMI20032259A1 (en) 2003-11-20 2005-05-21 Chemi Spa NEW POLYMORPHOUS OF ACID 1-CYCLOPROPYL-7- (S, S-2,8-DIAZABICLO-4.3.0-NON-8-IL) -6-FLUORO-1,4-DIIDRO-8-METOSSI-4-OXO -CHINOLIN CARBOSXYL CHLORIDRATE AND METHODS FOR ITS PREPARATION
CN1244582C (en) * 2004-04-21 2006-03-08 中国医学科学院医药生物技术研究所 Compound of quinolone carboxylic acid, preparation method and medicinal usage
US7759362B2 (en) 2004-04-21 2010-07-20 Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
ES2284380B1 (en) * 2006-03-10 2008-11-01 Quimica Sintetica S.A. PROCEDURE FOR THE PREPARATION OF MOXIFLOXACINO AND MOXIFLOXACINO CHLORHYDRATE.
US20100204470A1 (en) 2006-06-27 2010-08-12 Sandoz Ag method for salt preparation
KR20150048920A (en) 2006-11-13 2015-05-07 씨아이피엘에이 엘티디. Process for the synthesis of moxifloxacin hydrochloride
WO2008059521A2 (en) * 2006-11-14 2008-05-22 Msn Laboratories Limited Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin
US7692015B2 (en) 2007-01-05 2010-04-06 Zheqing Wang Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer
WO2008102188A1 (en) 2007-02-22 2008-08-28 Tibor Nagy Procedure to manufacture and use beer and other types liquids treated with neodimium magnet
EP2083010A1 (en) 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
IT1393337B1 (en) 2009-03-06 2012-04-20 Italiana Sint Spa SUMMARY OF (4AS, 7AS) -OTTAIDRO-1H-PIRROLO [3,4-B] PYRIDINE
EP2423211B1 (en) * 2009-04-20 2014-04-16 Kaneka Corporation Processes for producing (1s,6s)- or (1r,6r)-cis-2,8-diazabicyclo[4.3.0]nonane and intermediate thereof
IT1398952B1 (en) 2010-03-19 2013-03-28 F S I Fabbrica Italiana Sint PROCESS OF PREPARATION OF MOXIFLOXACINE AND ITS SALTS
CN101941969B (en) * 2010-09-30 2012-05-23 江苏正大丰海制药有限公司 Preparation method of moxifloxacin hydrochloride
CN102675308A (en) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 Method for preparing 8-benzyl-2,8-diazabicyclo(4.3.0) nonane
CN102675307A (en) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 Method for preparing chiral compound 8-phenethyl-2,8-diazabicyclo[4.3.0]nonane
ITTO20110705A1 (en) 2011-07-29 2013-01-30 Italiana Sint Spa PROCEDURE FOR THE PREPARATION OF MOXIFLOXACINE CHLORIDRATE AND RELATED INTERMEDIATES
CN102964346B (en) * 2011-09-01 2015-04-22 中国中化股份有限公司 Preparation method of (S, S)-octahydro-6H-pyrrolo[3, 4-b]pyridine
CN103044418B (en) * 2011-10-14 2015-02-04 上海朴颐化学科技有限公司 Asymmetric synthesis method, relevant raw materials and preparation method of (S,S)-2,8-diazabicyclo[4,3,0] nonane
CN102408427B (en) * 2011-10-22 2012-12-12 浙江普洛康裕制药有限公司 Preparation method for moxifloxacin intermediate (1S, 6R)-8-benzyl-7, 9-dioxy-2, 8-diazabicyclo [4.3.0] nonane
BRPI1106900A2 (en) 2011-12-26 2013-11-05 Ems Sa SOLID PHARMACEUTICAL COMPOSITION UNDERSTANDING ANTIBOTH FAMILY OF QUINOLONES AND THE PROCESS OF OBTAINING THEM
FR2992218B1 (en) 2012-06-22 2015-01-23 Rivopharm Sa PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN HYDROCHLORIDE AND PROCESS FOR PREPARING THE SAME
WO2014087292A1 (en) 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
CN103012452B (en) * 2012-12-25 2015-12-02 浙江新和成股份有限公司 The preparation method of a kind of Moxifloxacin and hydrochloride thereof
UA106556C2 (en) * 2013-05-13 2014-09-10 Наталья Николаевна Деркач Method of obtaining (1-cyclopropyl -6- fluoro-1,4-dihydro methoxy -8 -7 - [(4as, 7as) - oktahydro -6n- pyrrolo [3,4-pyridine bsch - 6- yl] -4-oxo-3-hinolinkarbonovoyi acid
CN103724262B (en) * 2013-12-10 2016-05-18 广东省第二人民医院 A kind of fluoquinolone silver compound and its production and use
CN104860944A (en) * 2015-06-09 2015-08-26 内蒙古东北六药集团有限公司 Production method of moxifloxacin hydrochloride
CN108872413B (en) * 2018-04-27 2021-06-08 山东齐都药业有限公司 Method for detecting enantiomer content in (S, S) -2, 8-diazabicyclo [4,3,0] nonane
CN110627768B (en) * 2018-06-22 2021-11-09 扬子江药业集团有限公司 Preparation method of moxifloxacin degradation impurity J
CN110183445B (en) * 2019-06-28 2021-08-24 昆明学院 Synthetic method of moxifloxacin and derivatives thereof
RU2713932C1 (en) * 2019-10-31 2020-02-11 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Fluoroquinolone compounds based on pyridoxine derivatives, having antibacterial properties
CN112939849B (en) * 2019-12-11 2022-05-03 浙江新和成股份有限公司 (S, S) -2, 8-diazabicyclo [4.3.0] nonane intermediate and preparation method and application thereof
CN110981874A (en) * 2020-03-05 2020-04-10 北京四环生物制药有限公司 Preparation method of moxifloxacin hydrochloride
CN112409352B (en) * 2020-11-20 2022-05-24 华南理工大学 Moxifloxacin drug derivatives and preparation method and application thereof
CN112574197B (en) * 2020-12-07 2021-12-31 泰安汉威集团有限公司 Chiral purification method of compound C

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0754229B2 (en) * 1987-09-28 1995-06-07 松下冷機株式会社 refrigerator
DE3906365A1 (en) * 1988-07-15 1990-01-18 Bayer Ag 7- (1-PYRROLIDINYL) -3-CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES, METHOD AND SUBSTITUTED (OXA) DIAZABICYCLOOCTANES AND NONANESE AS INTERMEDIATE PRODUCTS, AND ANTIBACTERIAL AGENTS AND FOOD ADDITIVES CONTAINING THEM
FI901201A0 (en) * 1989-03-13 1990-03-09 Bristol Myers Squibb Co ANTIBAKTERIELLA 5-SUBSTITUERADE 1,4-DIHYDRO-4-OXONAFTYRIDIN-3-CARBOXYLATDERIVAT OCH DERAS FRAMSTAELLNING.
DE3910663A1 (en) * 1989-04-03 1990-10-04 Bayer Ag 5-ALKYLCHINOLON CARBONIC ACIDS
JPH03188080A (en) * 1989-12-15 1991-08-16 Banyu Pharmaceut Co Ltd Pyridonecarboxylic acid derivative

Also Published As

Publication number Publication date
FI110943B (en) 2003-04-30
NO924978L (en) 1993-07-12
PL174853B1 (en) 1998-09-30
SK2232000A3 (en) 2006-05-04
FI990207A0 (en) 1999-02-03
TW209865B (en) 1993-07-21
JP4111431B2 (en) 2008-07-02
CN1075499C (en) 2001-11-28
HU9300034D0 (en) 1993-04-28
FI20020059A (en) 2002-01-11
PL297338A1 (en) 1993-09-06
NO924978D0 (en) 1992-12-22
JP2003026574A (en) 2003-01-29
AU3105493A (en) 1993-07-15
JP2003048890A (en) 2003-02-21
FI930049A0 (en) 1993-01-07
KR930016421A (en) 1993-08-26
HUT64065A (en) 1993-11-29
NO301420B1 (en) 1997-10-27
MY115416A (en) 2003-06-30
FI113771B (en) 2004-06-15
CN1043142C (en) 1999-04-28
CN1192440A (en) 1998-09-09
EP0550903A1 (en) 1993-07-14
NZ245640A (en) 1995-03-28
FI930049A (en) 1993-07-11
CA2086914C (en) 2005-03-15
KR100251886B1 (en) 2000-07-01
AU669502B2 (en) 1996-06-13
FI104174B (en) 1999-11-30
SK285155B6 (en) 2006-07-07
JPH05271229A (en) 1993-10-19
SK285223B6 (en) 2006-09-07
SK2212000A3 (en) 2006-05-04
CA2086914A1 (en) 1993-07-11
CZ289076B6 (en) 2001-10-17
SK396692A3 (en) 2002-09-10
FI990207A (en) 1999-02-03
CN1212256A (en) 1999-03-31
HU219488B (en) 2001-04-28
CN1061351C (en) 2001-01-31
MX9207604A (en) 1993-10-01
SK282971B6 (en) 2003-01-09
CZ396692A3 (en) 1993-08-11
CN1074218A (en) 1993-07-14

Similar Documents

Publication Publication Date Title
FI104174B1 (en) A process for the preparation of a therapeutically useful nonane isomer of 1,4-dihydro-4-oxo-3-quinolinecarboxylic acid 7- [S, S] -2,8-diazabicyclo [4.3.0]
NO175531C (en) Analogous Process for the Preparation of Therapeutically Active Imidazo (4,5-b) -quinolinyloxyalkanoic Acid Amides
NO179639C (en) Analogous process for the preparation of therapeutically active substituted piperidine compounds
NO179584C (en) Analogous Process for the Preparation of Therapeutically Active 2-Acylaminothiazoles
NO975775D0 (en) Process for the preparation of compounds having antifugal activity
IL96398A0 (en) Therapeutically active chloro substituted benzimidazoles processes for their preparation as well as their use
NO175978C (en) Analogous process for the preparation of therapeutically active bis-aza-bicyclic compounds
NO180586C (en) Analogous process for the preparation of therapeutically active substituted imidazoles
NO179448C (en) Analogous process for the preparation of therapeutically active compounds
NO178619C (en) Analogous process for the preparation of therapeutically active di-t-butylphenols
NO900032L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOL COMPOUNDS.
NO864879D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE THIASOL COMPOUNDS.
NO175714C (en) Analogous process for the preparation of therapeutically active aromatic esters
NO177096C (en) Analogous process for the preparation of therapeutically active, substituted isoquinolines
EP0487986A3 (en) Process for the preparation of esters of (6s)-6,8-dihydroxyoctanoic acid
FI880467A0 (en) Process for the preparation of therapeutically useful substituted 3,4-dihydro-2H-benzopyrans
FI871087A0 (en) Process for the preparation of therapeutically active 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo / oxo-5-pyrimidinecarboxylic acid derivatives
FI900897A0 (en) Analogous process for the preparation of therapeutically useful 4,5,6,7-tetrahydroimidazo [4,5,1-jk] 1,4 / benzodiazepine-2 (1H) -thion derivatives
NO174892C (en) Analogous Process for Preparation of Therapeutically Active, Substituted Dihydropyrrolizine Compounds
NO175781C (en) Analogous Process for Preparing Therapeutically Active Tetracyclic Compounds
FI892684A (en) Process for the preparation of therapeutically active 4-oxoimidazo [1,5-a] quinoxaline derivatives
FI890503A0 (en) Process for the preparation of therapeutically useful 1-cyclopropyl-6-fluoro-7- (3,3-disubstituted-1-pyrrolidinyl) -1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
NO174774C (en) Analogous Process for the Preparation of Therapeutically Active Benzodiazepines
NO174203C (en) Analogous Process for the Preparation of Therapeutically Active
NO172495C (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE, NON-Saturated AMINO ACID COMPOUNDS

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

MA Patent expired